BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 27396811)

  • 1. Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study.
    Mazeron R; Fokdal LU; Kirchheiner K; Georg P; Jastaniyah N; Šegedin B; Mahantshetty U; Hoskin P; Jürgenliemk-Schulz I; Kirisits C; Lindegaard JC; Dörr W; Haie-Meder C; Tanderup K; Pötter R;
    Radiother Oncol; 2016 Sep; 120(3):412-419. PubMed ID: 27396811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI-guided brachytherapy in locally advanced cervical cancer: Small bowel [Formula: see text] and [Formula: see text] are not predictive of late morbidity.
    Petit C; Dumas I; Chargari C; Martinetti F; Maroun P; Doyeux K; Tailleur A; Haie-Meder C; Mazeron R
    Brachytherapy; 2016; 15(4):463-470. PubMed ID: 27180130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermediate dose-volume parameters and the development of late rectal toxicity after MRI-guided brachytherapy for locally advanced cervix cancer.
    Ujaimi R; Milosevic M; Fyles A; Beiki-Ardakani A; Carlone M; Jiang H; Lindsay P; Xie J; Gerber R; Croke J; Skliarenko J; Levin W; Han K
    Brachytherapy; 2017; 16(5):968-975.e2. PubMed ID: 28757404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsed-dose rate image-guided adaptive brachytherapy in cervical cancer: Dose-volume effect relationships for the rectum and bladder.
    Mazeron R; Maroun P; Castelnau-Marchand P; Dumas I; del Campo ER; Cao K; Slocker-Escarpa A; M'Bagui R; Martinetti F; Tailleur A; Guemnie-Tafo A; Morice P; Chargari C; Lefkopoulos D; Haie-Meder C
    Radiother Oncol; 2015 Aug; 116(2):226-32. PubMed ID: 26164773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Late Urinary Complications Following Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: Refining Bladder Dose-Volume Parameters.
    Manea E; Escande A; Bockel S; Khettab M; Dumas I; Lazarescu I; Fumagalli I; Morice P; Deutsch E; Haie-Meder C; Chargari C
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):411-420. PubMed ID: 29559282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study.
    Kirchheiner K; Nout RA; Tanderup K; Lindegaard JC; Westerveld H; Haie-Meder C; Petrič P; Mahantshetty U; Dörr W; Pötter R
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):88-95. PubMed ID: 24725693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
    Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
    Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A volumetric analysis of GTV
    Jastaniyah N; Yoshida K; Tanderup K; Lindegaard JC; Sturdza A; Kirisits C; Šegedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz IM; Haie-Meder C; Banerjee S; Pötter R;
    Radiother Oncol; 2016 Sep; 120(3):404-411. PubMed ID: 27452409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post radiation hysterectomy in locally advanced cervical cancer: Outcomes and dosimetric impact.
    Mazeron R; Gouy S; Chargari C; Rivin Del Campo E; Dumas I; Mervoyer A; Genestie C; Bentivegna E; Balleyguier C; Pautier P; Morice P; Haie-Meder C
    Radiother Oncol; 2016 Sep; 120(3):460-466. PubMed ID: 27492204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician assessed and patient reported urinary morbidity after radio-chemotherapy and image guided adaptive brachytherapy for locally advanced cervical cancer.
    Fokdal L; Pötter R; Kirchheiner K; Lindegaard JC; Jensen NBK; Kirisits C; Chargari C; Mahantshetty U; Jürgenliemk-Schulz IM; Segedin B; Hoskin P; Tanderup K
    Radiother Oncol; 2018 Jun; 127(3):423-430. PubMed ID: 29784450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early morbidity and dose-volume effects in definitive radiochemotherapy for locally advanced cervical cancer: a prospective cohort study covering modern treatment techniques.
    Seppenwoolde Y; Majercakova K; Buschmann M; Dörr E; Sturdza AE; Schmid MP; Pötter R; Georg D
    Strahlenther Onkol; 2021 Jun; 197(6):505-519. PubMed ID: 33929558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer.
    Pötter R; Georg P; Dimopoulos JC; Grimm M; Berger D; Nesvacil N; Georg D; Schmid MP; Reinthaller A; Sturdza A; Kirisits C
    Radiother Oncol; 2011 Jul; 100(1):116-23. PubMed ID: 21821305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study.
    Pötter R; Tanderup K; Schmid MP; Jürgenliemk-Schulz I; Haie-Meder C; Fokdal LU; Sturdza AE; Hoskin P; Mahantshetty U; Segedin B; Bruheim K; Huang F; Rai B; Cooper R; van der Steen-Banasik E; Van Limbergen E; Pieters BR; Tan LT; Nout RA; De Leeuw AAC; Ristl R; Petric P; Nesvacil N; Kirchheiner K; Kirisits C; Lindegaard JC;
    Lancet Oncol; 2021 Apr; 22(4):538-547. PubMed ID: 33794207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between the ICRU rectal point and modern volumetric parameters in brachytherapy for locally advanced cervical cancer.
    Mazeron R; Kamsu Kom L; Rivin del Campo E; Dumas I; Farha G; Champoudry J; Chargari C; Martinetti F; Lefkopoulos D; Haie-Meder C
    Cancer Radiother; 2014 Jun; 18(3):177-82. PubMed ID: 24751222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overall Severe Morbidity After Chemo-Radiation Therapy and Magnetic Resonance Imaging-Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study.
    Vittrup AS; Kirchheiner K; Pötter R; Fokdal LU; Jensen NBK; Spampinato S; Haie-Meder C; Schmid MP; Sturdza AE; Mahantshetty U; Hoskin P; Segedin B; Bruheim K; Rai B; Wiebe E; van der Steen-Banasik E; Cooper R; Van Limbergen E; Sundset M; Pieters BR; Kirisits C; Lindegaard JC; Jürgenliemk-Schulz IM; Nout R; Tanderup K;
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):807-824. PubMed ID: 36641039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Castelnau-Marchand P; Chargari C; Maroun P; Dumas I; Del Campo ER; Cao K; Petit C; Martinetti F; Tafo-Guemnie A; Lefkopoulos D; Morice P; Haie-Meder C; Mazeron R
    Gynecol Oncol; 2015 Nov; 139(2):288-94. PubMed ID: 26364808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results.
    Dimopoulos JC; Schmid MP; Fidarova E; Berger D; Kirisits C; Pötter R
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1880-8. PubMed ID: 21868174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship Between Late Morbidity and Dose-Volume Parameter of Rectum in Combined Intracavitary/Interstitial Cervix Cancer Brachytherapy: A Mono-Institutional Experience.
    Zhang N; Liu Y; Han D; Guo X; Mao Z; Yang W; Cheng G
    Front Oncol; 2021; 11():693864. PubMed ID: 34367976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy.
    Mazeron R; Castelnau-Marchand P; Dumas I; del Campo ER; Kom LK; Martinetti F; Farha G; Tailleur A; Morice P; Chargari C; Lefkopoulos D; Haie-Meder C
    Radiother Oncol; 2015 Feb; 114(2):257-63. PubMed ID: 25497872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.